MONTREAL, QUEBEC--(Marketwire - September 10, 2008) - ATTENTION BUSINESS/FINANCIAL/HEALTH EDITORS Ambrilia Biopharma Inc. (TSX: AMB) today announced that Dr. Philippe Calais, President and CEO, will present the Company and its projects at the Sachs Associates 8th Annual Biotech in Europe Investor Forum to be held in Zurich, September 23-24. This presentation will take place on Tuesday, September 23, Basel room (Swissotel), at 2:30 pm local time.
